The right material.

The right resolution.

Next-gen microfluidics.

Phase’s proprietary platform enables PDMS and other biocompatible materials to be 3D printed at a commercial scale and a previously unattainable resolution.

Our innovation creates microfluidics in industry-standard materials at a speed that propels bioinnovation across the biotech industry.

Phase's 3D printed microfluidics can include valves, sensors, and electrodes that are integrated during the printing process. Our proprietary technology yields a highly automated and reproducible process that allows for rapid customized iterations and scalable production.

Backed by three NIH grants, Phase, Inc. is currently working with Harvard Medical School, Georgia Tech, and Virginia Tech to develop a microfluidic device that will allow researchers to develop new brain cancer treatments.

With a team of seasoned leaders in both 3D printing and biomedical engineering with advanced degrees from MIT and UC Berkeley, Phase is poised to lead the microfluidics industry in unlocking the next wave of medical breakthroughs.

Announcements

Phase, Inc. partners with Harvard Medical School, Georgia Tech, Virginia Tech on $1.8M NIH grant to 3D print microfluidic organ-on-a-chip models

Phase, Inc. awarded funding from NC Biotech to develop organ-on-a-chip solutions

Phase, Inc., on path to commercialization of 3D printed microfluidic devices with grant from North Carolina Office of Science, Technology & Innovation

All announcements

Phase in the News

Charlotte Inno

Cornelius startup Phase receives $1.8M grant from National Institutes of Health for 3D-printing project

3D Printing Industry

Phase, Inc., on path to commercialization of 3D printed microfluidic devices with grant from North Carolina Office of Science, Technology & Innovation

TCT Magazine

Phase, Inc. partners with Harvard Medical School, Georgia Tech, Virginia Tech on $1.8M NIH grant to 3D print microfluidic organ-on-a-chip models

All news

The right material.

The right resolution.

Next-gen microfluidics.

Announcements

Phase, Inc. partners with Harvard Medical School, Georgia Tech, Virginia Tech on $1.8M NIH grant to 3D print microfluidic organ-on-a-chip models

Phase, Inc. awarded funding from NC Biotech to develop organ-on-a-chip solutions

Phase, Inc., on path to commercialization of 3D printed microfluidic devices with grant from North Carolina Office of Science, Technology & Innovation

Phase in the News

Cornelius startup Phase receives $1.8M grant from National Institutes of Health for 3D-printing project

Phase, Inc., on path to commercialization of 3D printed microfluidic devices with grant from North Carolina Office of Science, Technology & Innovation

Phase, Inc. partners with Harvard Medical School, Georgia Tech, Virginia Tech on $1.8M NIH grant to 3D print microfluidic organ-on-a-chip models

Let's partner.